1. Stocks
  2. Mankind Pharma Ltd.
  3. Swot
swot-logo

Mankind Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Mankind Pharma Ltd. has 13 Strengths, 7 Weaknesses, 4 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Benjamin Graham Value Screen

Strong Momentum: Price above short, medium and long term moving averages

Expensive Rockets (DVM)

Relative Outperformance versus Industry over 1 Year

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Increasing profits every quarter for the past 2 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Stocks Outperforming their Industry Price Change in the Quarter

Promoter decreasing their shareholding

PE higher than Industry PE

High PE (PE > 40)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Declining Net Cash Flow : Companies not able to generate net cash

Top Losers

Declining profitability: Falling ROCE

Brokers upgraded recommendation or target price in the past three months

FII / FPI or Institutions increasing their shareholding

Weekly Momentum Gainers

Mutual Funds Increased Shareholding over the Past Two Months

Companies with high market cap, lower public shareholding

MFs decreased their shareholding last quarter

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks